Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Stereotaxis Inc

STXS ✓ COMPLIANT ☆ Track — members

NYSE American · Healthcare · Advanced Medical Equipment & Technology ·

USA Micro Cap Analyst: BUY

Last Close

$1.38

▲ +0.00%

Market Cap $138.28M · Vol 129.47K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$138.28M

Micro Cap

Div Yield

N/A

EPS Growth

+17.33%

YoY

RSI (14)

57.41

Momentum

Beta

1.42

vs Market

52W High

$3.59

61.56% below

52W Low

$1.24

11.29% above

Volume

129.47K

Avg 113.29K

P/B

16.27

Price-to-book

ROE

N/A

Return on equity

Free Float

82.34%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Stereotaxis Inc (STXS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does STXS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.82%

-13.75%

-28.87%

-30.65%

YTD

-40.00%

-52.41%

-11.54%

-79.56%

Financials & Valuation

TTM · Annual

Total Revenue	$32.38M
Net Income	$-21,643,000.00
Revenue Growth (YoY)	-12.82%
Gross Margin	52.73%
Operating Margin	-63.11%
Net Profit Margin	-66.85%
ROE	N/A
ROA · ROIC	-43.73% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	6.46
P/B	16.27
P/FCF	N/A
EPS Growth	+17.33%
Outstanding Shares	100.20M

Technical Indicators

50-Day SMA	$1.61
200-Day SMA	$2.05
RSI (14)	57.41
Beta	1.42
52-Week High	$3.59
52-Week Low	$1.24

Volume Today	129.47K
Avg Daily Volume (30D)	113.29K
Relative Volume	1.14x
Volatility (10D)	53.70
Volatility (30D)	57.67
Free Float	82.34%

Analyst Consensus

BUY

Current Price $1.38

Mean Target $3.33

52W Low$1.24 52W High$3.59

Current

Target

$1.24 $3.59

Current Analyst target

+141.55% upside potential · 3 analysts

Identifiers

ExchangeNYSE American

FIGIBBG001SKC124

ISINUS85916J4094

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 11, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.